In contrast, pathways that have been proposed to explain T2DM‐cancer associations (hyperinsulinemia, hyperglycemia, IGF signaling, and inflammation) have also been proposed as possible mediators for the BMI‐cancer relationship.7, 35, 36, 37, 38, 39. This evidence concerns the gene IGF1 and Hyperinsulinemia.